Every material Form 8-K Bath & Body Works filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Bath & Body Works reported third-quarter 2024 net sales of $1,610 million, up 3.0%, but diluted earnings per share fell to $0.49 from $0.52 a year earlier. The company raised its full-year 2024 earnings and net sales guidance, while its fourth-quarter outlook calls for net sales to decline 4.5% to 6.5% and earnings per share of $1.94 to $2.07 versus $2.55 a year earlier.
Q3 2024 net sales were $1,610 million, up 3.0% from $1,562 million; net income was $106 million versus $119 million
Q3 diluted EPS was $0.49 versus $0.52; adjusted EPS was $0.49 versus $0.48 after excluding a 2023 debt-extinguishment gain
Full-year 2024 GAAP EPS guidance raised to $3.46 to $3.59, including $400 million of planned share repurchases
Fourth-quarter 2024 net sales expected to decline 6.5% to 4.5%, with EPS of $1.94 to $2.07 versus $2.55 in Q4 2023
Bath & Body Works said Julie Rosen stepped down as President, Retail, effective immediately on September 25, 2024, and that the role has been eliminated, with her functions reporting to CEO Gina Boswell. The company also reaffirmed its third quarter and full year fiscal 2024 guidance, first given on August 28, 2024. Ms. Rosen's employment is expected to end on or about October 22, 2024, with severance payable under her existing agreement if she remains in good standing and signs a release.
Julie Rosen ceased to serve as President, Retail on September 25, 2024; she will act in an advisory or transition role until her expected separation date of about October 22, 2024
The President, Retail role has been eliminated, and its functions now report to CEO Gina Boswell
Third quarter and full year fiscal 2024 guidance reaffirmed, as previously provided on August 28, 2024
Bath & Body Works reported second quarter 2024 net sales of $1,526 million, down 2.1% from $1,559 million a year earlier, and adjusted earnings per diluted share of $0.37 versus $0.40. The company updated its full-year 2024 guidance and raised planned share repurchases to $400 million from $300 million, while reported earnings per share rose to $0.68 on one-time gains and a tax benefit.
Q2 2024 net sales $1,526 million, down 2.1%; reported EPS $0.68 vs. $0.43, adjusted EPS $0.37 vs. $0.40
Reported Q2 results include a $39 million pre-tax gain on Easton investment sales and a $44 million tax benefit
Full-year 2024 adjusted EPS guidance $3.06 to $3.26, vs. $3.27 adjusted EPS in fiscal 2023; net sales guided to a decline of 4% to 2%
Planned share repurchases for 2024 increased to $400 million from $300 million; Q3 2024 EPS guidance $0.41 to $0.47
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Bath & Body Works filing is on SEC EDGAR ↗. 8-K briefs of other companies →